Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations

被引:32
|
作者
Mestre, Tiago A. [1 ]
Joao Forjaz, Maria [2 ,3 ]
Mahlknecht, Philipp [4 ]
Cardoso, Francisco [5 ]
Ferreira, Joaquim J. [6 ]
Reilmann, Ralf [7 ]
Sampaio, Cristina [8 ]
Goetz, Christopher G. [9 ]
Cubo, Esther [10 ,11 ]
Martinez-Martin, Pablo [12 ]
Stebbins, Glenn T. [9 ]
机构
[1] Univ Ottawa, Ottawa Hosp, Brain & Mind Inst, Div Neurol,Dept Med,Res Inst,Parkinsons Dis & Mov, Ottawa, ON, Canada
[2] Carlos III Inst Hlth, Natl Sch Publ Hlth, Dept Epidemiol & Biostat, Madrid, Spain
[3] Red Invest Serv Salud Enfermedades Cron REDISSEC, Madrid, Spain
[4] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria
[5] Univ Fed Minas Gerais, Internal Med Dept, Movement Disorders Unit, Neurol Serv, Belo Horizonte, MG, Brazil
[6] Univ Lisbon, Inst Mol Med, Neurol & Clin Pharmacol, Lisbon, Portugal
[7] George Huntington Inst, Munster, Germany
[8] CHDI Fdn, CHDI Management, Princeton, NJ USA
[9] Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA
[10] Carlos III Inst Hlth, Natl Ctr Epidemiol, Madrid, Spain
[11] Carlos III Inst Hlth, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain
[12] Hosp Univ Hermanos Yague, Dept Neurol, Burgos, Spain
来源
MOVEMENT DISORDERS CLINICAL PRACTICE | 2018年 / 5卷 / 02期
关键词
Chorea; Clinimetrics; Dyskinesia; Huntington's disease; Motor; Parkinsonism; rating scales; validation;
D O I
10.1002/mdc3.12571
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Motor symptoms are a major feature of Huntington's disease (HD). The International Parkinson and Movement Disorder Society (MDS) commissioned the assessment of the clinimetric properties of motor rating scales in HD to make recommendations regarding their use, following previously established standardized criteria. After a systematic literature search, a total of 6 rating scales assessing motor symptoms and signs in HD were included for review. Performance testing (reviewed elsewhere) and quantitative motor rating methods were excluded. Only the Unified Huntington's Disease Rating Scale-Total Motor Score (UHDRS-TMS) was classified as recommended for assessing the severity of motor signs in HD. The following scales were classified as suggested: Abnormal Involuntary Movement Scale, the UHDRS-TMS4, the Quantified Neurological Examination, and the Marsden and Quinn Chorea Severity Scale. The committee also concluded that further assessment of existing rating scales, including the UHDRS-TMS, is necessary to determine sensitivity to change and to screening for the presence of motor signs specific to HD. There is also a need to develop a motor rating scale to be used in positive gene carriers with subtle but not definite motor signs.
引用
收藏
页码:111 / 117
页数:7
相关论文
共 50 条
  • [21] A shortened version of the motor section of the unified Huntington's disease rating scale
    Siesling, S
    Zwinderman, AH
    vanVugt, JPP
    Kieburtz, K
    Roos, RAC
    MOVEMENT DISORDERS, 1997, 12 (02) : 229 - 234
  • [22] Scales and scores for assessment of non-motor symptoms in Parkinson's disease
    Schneider, C.
    Storch, A.
    NERVENHEILKUNDE, 2012, 31 (12) : 879 - 883
  • [23] The Movement Disorders Task Force Review of Dysautonomia Rating Scales in Parkinson's Disease with Regard to Symptoms of Orthostatic Hypotension
    Pavy-Le Traon, Anne
    Amarenco, Gerard
    Duerr, Susanne
    Kaufmann, Horacio
    Lahrmann, Heinz
    Shaftman, Stephanie R.
    Tison, Francois
    Wenning, Gregor K.
    Goetz, Christopher G.
    Poewe, Werner
    Sampaio, Cristina
    Schrag, Anette
    Stebbins, Glenn T.
    Rascol, Olivier
    MOVEMENT DISORDERS, 2011, 26 (11) : 1985 - 1992
  • [24] Varenicline improves motor and cognitive symptoms in early Huntington's disease
    McGregor, Ailsa L.
    Dysart, Jo
    Tingle, Malcolm D.
    Russell, Bruce R.
    Kydd, Rob R.
    Finucane, Gregory
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 2381 - 2386
  • [25] The improvement of motor symptoms in Huntington’s disease during cariprazine treatment
    Reka Csehi
    Viktor Molnar
    Mariann Fedor
    Vivien Zsumbera
    Agnes Palasti
    Karoly Acsai
    Zoltan Grosz
    Gyorgy Nemeth
    Maria Judit Molnar
    Orphanet Journal of Rare Diseases, 18
  • [26] Huntington's Disease Progression: A Population Modeling Approach to Characterization Using Clinical Rating Scales
    Sun, Wan
    Di Zhou
    Warner, John H.
    Langbehn, Douglas R.
    Hochhaus, Guenther
    Wang, Yaning
    JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (08) : 1051 - 1060
  • [27] The improvement of motor symptoms in Huntington's disease during cariprazine treatment
    Csehi, Reka
    Molnar, Viktor
    Fedor, Mariann
    Zsumbera, Vivien
    Palasti, Agnes
    Acsai, Karoly
    Grosz, Zoltan
    Nemeth, Gyorgy
    Molnar, Maria Judit
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [28] Non-motor symptoms in Huntington’s disease: a comparative study with Parkinson’s disease
    Tatiana Aldaz
    Pasquale Nigro
    Almudena Sánchez-Gómez
    Celia Painous
    Lluís Planellas
    Pilar Santacruz
    Ana Cámara
    Yaroslau Compta
    Francesc Valldeoriola
    Maria J. Martí
    Esteban Muñoz
    Journal of Neurology, 2019, 266 : 1340 - 1350
  • [29] Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales
    Samra, Kiran
    MacDougall, Amy M.
    Peakman, Georgia
    Bouzigues, Arabella
    Bocchetta, Martina
    Cash, David M.
    Greaves, Caroline, V
    Convery, Rhian S.
    van Swieten, John C.
    Jiskoot, Lize
    Seelaar, Harro
    Moreno, Fermin
    Sanchez-Valle, Raquel
    Laforce, Robert
    Graff, Caroline
    Masellis, Mario
    Tartaglia, Carmela
    Rowe, James B.
    Borroni, Barbara
    Finger, Elizabeth
    Synofzik, Matthis
    Galimberti, Daniela
    Vandenberghe, Rik
    de Mendonca, Alexandre
    Butler, Chris R.
    Gerhard, Alexander
    Ducharme, Simon
    Le Ber, Isabelle
    Tiraboschi, Pietro
    Santana, Isabel
    Pasquier, Florence
    Levin, Johannes
    Otto, Markus
    Sorbi, Sandro
    Rohrer, Jonathan D.
    Russell, Lucy L.
    JOURNAL OF NEUROLOGY, 2023, 270 (03) : 1466 - 1477
  • [30] Huntington's disease: Managing neuropsychiatric symptoms in Huntington's disease
    Loi, Samantha M.
    Walterfang, Mark
    Velakoulis, Dennis
    Looi, Jeffrey C. L.
    AUSTRALASIAN PSYCHIATRY, 2018, 26 (04) : 376 - 380